Ally Bridge Group (NY) LLC 13F holdings
Ally Bridge Group (NY) LLC reported 23 positions with a total reported value of $77.6M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-14. Top holdings by reported value: NERV MINERVA NEUROSCIENCES INC (15.6%), PMN PROMIS NEUROSCIENCES INC (10.5%), TRAX FIRST TRACKS BIOTHERAPEUTICS (7.4%), AXSM AXSOME THERAPEUTICS INC (5.2%), ASMB ASSEMBLY BIOSCIENCES INC (5.0%). Against 2026-03-31 it opened 10 new positions and exited 8. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Ally Bridge Group (NY) LLC files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
23 largest of 23 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| NERV MINERVA NEUROSCIENCES INC | 2,175,802 | $12.1M | 15.6% |
| PMN PROMIS NEUROSCIENCES INC | 620,319 | $8.2M | 10.5% |
| TRAX FIRST TRACKS BIOTHERAPEUTICS | 284,287 | $5.7M | 7.4% |
| AXSM AXSOME THERAPEUTICS INC | 16,493 | $4.0M | 5.2% |
| ASMB ASSEMBLY BIOSCIENCES INC | 140,000 | $3.8M | 5.0% |
| WHWK WHITEHAWK THERAPEUTICS INC | 817,939 | $3.7M | 4.8% |
| EWTX EDGEWISE THERAPEUTICS INC | 83,300 | $3.4M | 4.4% |
| CLYM CLIMB BIO INC | 249,172 | $3.2M | 4.2% |
| KURA KURA ONCOLOGY INC | 290,000 | $3.2M | 4.1% |
| CTMX CYTOMX THERAPEUTICS INC. | 775,000 | $2.9M | 3.7% |
| AVTX AVALO THERAPEUTICS INC | 150,000 | $2.8M | 3.6% |
| PALI PALISADE BIO INC | 1,229,000 | $2.6M | 3.3% |
| SLDB SOLID BIOSCIENCES INC | 255,959 | $2.6M | 3.3% |
| ANTX AN2 THERAPEUTICS INC | 526,315 | $2.5M | 3.3% |
| URGN UROGEN PHARMA LTD | 69,183 | $2.5M | 3.3% |
| CATX PERSPECTIVE THERAPEUTICS INC | 743,958 | $2.5M | 3.3% |
| IDYA IDEAYA BIOSCIENCES INC | 67,500 | $2.5M | 3.2% |
| IVA INVENTIVA SA | 634,800 | $2.4M | 3.1% |
| ALMS ALUMIS INC | 76,459 | $2.2M | 2.8% |
| OVID OVID THERAPEUTICS INC | 624,561 | $1.7M | 2.2% |
| EPRX EUPRAXIA PHARMACEUTICALS INC | 252,175 | $1.7M | 2.1% |
| IBIO IBIO INC | 390,147 | $682.8K | 0.9% |
| TRAW TRAWS PHARMA INC | 786,236 | $663.0K | 0.9% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 10 in all · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| TRAX FIRST TRACKS BIOTHERAPEUTICS | 284,287 | $5.7M | 7.4% |
| AXSM AXSOME THERAPEUTICS INC | 16,493 | $4.0M | 5.2% |
| ASMB ASSEMBLY BIOSCIENCES INC | 140,000 | $3.8M | 5.0% |
| CLYM CLIMB BIO INC | 249,172 | $3.2M | 4.2% |
| KURA KURA ONCOLOGY INC | 290,000 | $3.2M | 4.1% |
| AVTX AVALO THERAPEUTICS INC | 150,000 | $2.8M | 3.6% |
| PALI PALISADE BIO INC | 1,229,000 | $2.6M | 3.3% |
| IDYA IDEAYA BIOSCIENCES INC | 67,500 | $2.5M | 3.2% |
| IBIO IBIO INC | 390,147 | $682.8K | 0.9% |
| TRAW TRAWS PHARMA INC | 786,236 | $663.0K | 0.9% |
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 8 in all · reported value as of 2026-03-31
| Holding | Shares 2026-03-31 | Reported value | % of portfolio then |
|---|---|---|---|
| PRAX PRAXIS PRECISION MEDICINES I | 32,810 | $10.6M | 10.5% |
| SOLENO THERAPEUTICS INC | 200,000 | $6.7M | 6.7% |
| CMPS COMPASS PATHWAYS PLC | 1,045,000 | $5.8M | 5.7% |
| TARS TARSUS PHARMACEUTICALS INC | 80,859 | $5.7M | 5.6% |
| ABVX ABIVAX SA | 33,712 | $3.8M | 3.7% |
| CAPR CAPRICOR THERAPEUTICS INC | 113,899 | $3.5M | 3.4% |
| IKT INHIBIKASE THERAPEUTICS INC | 1,325,000 | $2.2M | 2.2% |
| RLMD RELMADA THERAPEUTICS INC | 210,525 | $1.5M | 1.5% |
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| NERV MINERVA NEUROSCIENCES INC | 1,655,500 | 2,175,802 | +31.4% | $12.1M |
| PMN PROMIS NEUROSCIENCES INC | 414,219 | 620,319 | +49.8% | $8.2M |
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| OVID OVID THERAPEUTICS INC | 2,818,459 | 624,561 | -77.8% | $1.7M |
| SLDB SOLID BIOSCIENCES INC | 766,974 | 255,959 | -66.6% | $2.6M |
| URGN UROGEN PHARMA LTD | 202,124 | 69,183 | -65.8% | $2.5M |
| EWTX EDGEWISE THERAPEUTICS INC | 161,000 | 83,300 | -48.3% | $3.4M |
| EPRX EUPRAXIA PHARMACEUTICALS INC | 660,375 | 252,175 | -61.8% | $1.7M |
| ALMS ALUMIS INC | 166,959 | 76,459 | -54.2% | $2.2M |
| CATX PERSPECTIVE THERAPEUTICS INC | 926,557 | 743,958 | -19.7% | $2.5M |
| CTMX CYTOMX THERAPEUTICS INC. | 900,000 | 775,000 | -13.9% | $2.9M |
| IVA INVENTIVA SA | 745,300 | 634,800 | -14.8% | $2.4M |
CIK 1822947 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
